Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 11/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
56 |
| 11/02/20 | 8-K | Current report filing |
|
20 | |
| 10/15/20 | 8-K | Current report filing |
|
3 | |
| 10/15/20 | 8-K | Current report filing |
|
6 | |
| 10/02/20 | 8-K | Current report filing |
|
3 | |
| 09/29/20 | 8-K | Current report filing |
|
50 | |
| 09/16/20 | 8-K | Current report filing |
|
44 | |
| 09/15/20 | 8-K | Current report filing |
|
6 | |
| 09/04/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
42 | |
| 09/04/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
1 |
